Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

NCT00988208 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1059

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Lenalidomide
DRUG: Docetaxel
DRUG: Prednisone
DRUG: Placebo

Sponsor

Celgene